Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
about
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.Genomic Disparities in Breast Cancer Among Latinas.Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment.Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer.Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.The Ethnic-Specific Spectrum of Germline Nucleotide Variants in DNA Damage Response and Repair Genes in Hereditary Breast and Ovarian Cancer Patients of Tatar DescentComprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility
P2860
Q33784408-89787463-6A95-468D-9EDC-9F20701D851CQ37509093-A34D8EED-6AB6-46F8-968E-1675FF34F944Q37666821-3E289F94-70FB-4A93-96B6-97A1D9726179Q47110043-1FF23F51-1294-46F0-8FD3-62EB79C2C17EQ47260838-0EA4B9B8-6683-4339-B27D-D6C930CFF3BBQ48110433-68788C89-F32D-42A1-A732-F7D2440ED562Q49153890-F971B58C-C10F-4697-BCE4-021E53C5FC72Q51362287-BF6AA9BE-5D42-4442-8EC6-1EDACF6F84C1Q51764547-54D52FA8-41F7-4274-8C87-EFF4DD85531CQ55207798-8B7C86D4-2A67-4849-B68C-0081D6A39D92Q58586826-FF964295-0E62-4794-A0F9-9695A96CD7D0Q58930584-45549F32-BA37-4B13-A09B-924BE4D77462
P2860
Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeted massively parallel se ...... t and ovarian cancer families.
@en
Targeted massively parallel se ...... t and ovarian cancer families.
@nl
type
label
Targeted massively parallel se ...... t and ovarian cancer families.
@en
Targeted massively parallel se ...... t and ovarian cancer families.
@nl
prefLabel
Targeted massively parallel se ...... t and ovarian cancer families.
@en
Targeted massively parallel se ...... t and ovarian cancer families.
@nl
P2093
P2860
P50
P1476
Targeted massively parallel se ...... t and ovarian cancer families.
@en
P2093
Bing-Jian Feng
David Clouston
David Goldgar
Gillian Mitchell
Huong Meeks
Igor Makunin
Jonathan Ellis
Sue Healey
P2860
P356
10.1136/JMEDGENET-2015-103452
P407
P577
2015-11-03T00:00:00Z